Dr. Nicole P. Chappell, MD

Dr. Chappell practices at Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health.

Dr. Chappell's NPI, 1205010980, was assigned on December 18, 2007. Dr. Chappell graduated from Boston University School of Medicine in 2005. Dr. Chappell holds District of Columbia license MD049251.

Dr. Chappell's primary practice is Beth Israel Deaconess Medical Center, at 330 Brookline Avenue, Boston, MA 02215 in Suffolk County. The practice phone is (617) 667-7000.

Dr. Chappell's primary practice is Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health. Dr. Chappell is also affiliated with Beth Israel Deaconess Hospital-Plymouth. The medical group on file is Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP). Dmand AI also links Dr. Chappell to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chappell practices, 3 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Chappell's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dmand AI has Dr. Chappell's licenses on file in 3 states: District of Columbia, Massachusetts and Virginia.

CMS data shows 324 Medicare services from Dr. Chappell across 5 procedure codes in 2024, for 94 Medicare patients. Medicare paid $29,374 for them. Every service was in an office.

CMS counts 94 Medicare patients who saw Dr. Chappell in 2024. The largest group is 65 to 74, with 44 patients. 72% of them have high cholesterol, and 67% have cancer. 33% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chappell's median patient age at 71, with 96% women.

In 2024, Dr. Chappell wrote 125 Medicare Part D claims for 30 patients. 76% of them were for generic drugs. CMS names the drug for 42 of them, across 3 drugs with 11 or more claims each, at $335,550 in total drug cost. In 2023, CMS named 91 claims across 6 drugs.

Dr. Chappell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chappell as offering telehealth. CMS counts 12 procedures of removal of the uterus by Dr. Chappell, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 14 papers to Dr. Chappell, published from 2012 to 2025. 2022 was the busiest year, with 3. The most frequent topics are Endometrial Neoplasms, Uterine Cervical Neoplasms and Carcinoma, Squamous Cell. Dr. Chappell's most frequent co-authors are Jason Cory Barnett, MD, George Larry Maxwell, MD and Yovanni Casablanca, MD.

CMS Open Payments shows 16 general payments to Dr. Chappell from 11 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $208.

Dr. Chappell graduated from Boston University School of Medicine in 2005.